Expression of inducible nitric oxide synthase is increased in patients with heart failure due to ischemic disease

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 9, 2004, Pages 1313-1320

  Ferreiro, C R ^a   Chagas, A C P ^a   Carvalho, M H C ^a   Dantas, A P ^a   Scavone, C ^a   Souza, L C B ^a   Buffolo, E ^a   da Luz, P L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Heart failure; Left ventricle ejection fraction; Nitric oxide synthase

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITRULLINE; COMPLEMENTARY DNA; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM; HEART SURGERY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

DIGITALIS;

EID: 4444283872     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000900005     Document Type: Article

References (40)

1. Moncada S & Higgs A (1993). The L-arginine-nitric oxide pathway. New England Journal of Medicine, 329: 2002-2012.
2. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288: 373-376.
3. Palmer RMJ, Ferrige AG & Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327: 415-423.
4. Moncada S, Higgs A & Furchgott R (1997). XIV International union of pharmacology nomenclature in nitric oxide research. Pharmacological Reviews, 49: 137-142.
5. Laurindo FRM & Leite PF (2003). Síntese do óxido nítrico. In: da Luz PL, Laurindo FRM & Chagas ACP (Editors), Endotélio e Doenças Cardiovasculares. Vol. 4. Editora Atheneu, São Paulo, SP Brazil, 43-51.
6. Papapetropoulos A, Rudic RD & Sessa WC (1999). Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovascular Research, 43: 509-520.
7. Zweier JL, Wang P & Samouilov A (1995). Enzyme-independent formation of nitric oxide in biological tissues. Nature Medicine, 8: 804-809.
8. Wilcox JN, Subramanian RRCL & Sundell CL (1997). Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arteriosclerosis, Thrombosis, and Vascular Biology, 17: 2479-2488.
9. Nadaud S & Sobrier F (1996). Molecular biology and molecular genetics of nitric oxide synthase genes. Clinical and Experimental Hypertension, 18: 113-143.
10. Forstemann U, Closs EI & Pollock JS (1994). Nitric oxyde synthase isozymes: characterization, purification, molecular cloning and functions. Hypertension, 23 (Part 2): 1121-1131.
11. Brutsaert DL, Meulemans AL, Sipido KR & Sys SU (1988). Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circulation Research, 62: 357-366.
12. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG & Simmons RL (1992). Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 257: 387-389.
13. 2+-independent nitric oxide synthase in the myocardium. British Journal of Pharmacology, 105: 575-580.
14. de Belder AJ, Radomski MW, Why HJ, Richardson PJ & Martin JF (1995). Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and portpartum cardiomyopathy but not in ischaemic or valvar heart disease. British Heart Journal 74: 426-429.
15. Thoenes M, Forstermann U & Tracey WR (1996). Expression of inducible nitric oxide synthase in failing and non-failing human heart. Journal of Molecular and Cellular Cardiology, 28: 165-169.
16. Haywood GA, Tsao PS & Von Der Leyen HE (1996). Expression of inducible nitric oxide synthase in human failing heart. Circulation, 93: 1087-1094.
17. Habib FM, Springal DR & Davies GJ (1996). Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet, 347: 1151-1155.
18. Satoh M, Nakamura M & Tamura G (1997). Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. Journal of the American College of Cardiology, 29: 716-724.
19. de Belder AJ, Radomski M, Why H, Richardson PJ & Moncada S (1993). Nitric oxide synthase activities in human myocardium. Lancet, 341: 84-85.
20. Stein B, Eschenhagen T & Rudiger J (1998). Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. Journal of the American College of Cardiology, 32: 1179-1186.
21. Nissen SE, Elion JL, Grayburn P, Booth DC, Wisenbaugh TW & DeMaria AN (1987). Determination of left ventricular ejection fraction by computer densitometric analysis of digital subtraction angiography: experimental validation and correlation with area-length methods. American Journal of Cardiology. 59: 675-680.
22. McKee M, Scavone C & Nathanson JA (1994). Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proceedings of the National Academy of Sciences, USA, 91: 12056-12060.
23. Bradford M (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry, 72: 248-254.
24. Teng KS, Murthy JF & Kuemmerle JR (1998). Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. American Journal of Physiology, 275: G342-G351.
25. Winegrad S (1997). Endothelial cell regulation of contractility of the heart. Annual Review of Physiology, 59: 505-525.
26. Michel T & Feron O (1997). Nitric oxide synthases: which, where, how, and why? Journal of Clinical Investigation, 100: 2146-2152.
27. Heymes C, Vanderheyden M & Bronzwaer JGF (1999). Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation, 99: 3009-3016.
28. Drexler H, Kastner S & Strobel A (1998). Expression and functional significance of inducible nitric oxide synthase in the failing human heart. Journal of the American College of Cardiology, 32: 955-963.
29. Ferreiro CR, Chagas ACP, Carvalho MHC, Dantas AP, Jatene MB, Souza LCB & da Luz PL (2001). Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease. Circulation, 103: 2272-2276.
30. Kim YM, Bombeck CA & Billiar TR (1999). Nitric oxide as a bifunctional regulator of apoptosis. Circulation Research, 84: 253-256.
31. Ing DJ, Zang J & Dzau VJ (1999). Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circulation Research, 84: 21-33.
32. Pinsky D, Cai B & Yang X (1994). Nitric oxide-dependent killing of cardiac myocytes by adjacent macrophages. Circulation, 90 (Suppl 1): I-192.
33. Price S, Anning PB, Mitchell JA & Evans TW (1999). Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. European Heart Journal, 20: 715-724.
34. Ullrich R, Scherrer CM & Bloch KD (2000). Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation, 102: 1440-1446.
35. Kasai K, Hattori Y & Banba N (1997). Induction of tetrahydrobiopterin synthesis in rat cardiac myocytes: impact on cytokine-induced NO generation. American Journal of Physiology, 273: H665-H672.
36. Sasayama S, Matsumori A & Kihara Y (1999). New insights into the pathophysiological role for cytokines in heart failure. Cardiovascular Research, 42: 557-564.
37. Torre AG, Kapadia S & Lee J (1996). Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation, 93: 704-711.
38. Oral H, Dorn 2nd GW & Mann DL (1997). Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. Journal of Biological Chemistry, 272: 4836-4842.
39. Kubota T, McTiernan CF & Frye CS (1997). Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circulation Research, 81: 627-635.
40. Kalra D, Baumgarten G & Dibbs Z (2000). Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway. Circulation, 102: 1302-1307.